DK53285A - (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme - Google Patents
(-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme Download PDFInfo
- Publication number
- DK53285A DK53285A DK53285A DK53285A DK53285A DK 53285 A DK53285 A DK 53285A DK 53285 A DK53285 A DK 53285A DK 53285 A DK53285 A DK 53285A DK 53285 A DK53285 A DK 53285A
- Authority
- DK
- Denmark
- Prior art keywords
- methoxyphenoxy
- methylpiperidine
- trans
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/577,844 US4585777A (en) | 1984-02-07 | 1984-02-07 | (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK53285D0 DK53285D0 (da) | 1985-02-06 |
| DK53285A true DK53285A (da) | 1985-08-08 |
Family
ID=24310381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK53285A DK53285A (da) | 1984-02-07 | 1985-02-06 | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4585777A (de) |
| EP (1) | EP0152273B1 (de) |
| JP (1) | JPS60181071A (de) |
| AT (1) | ATE46146T1 (de) |
| CA (1) | CA1246082A (de) |
| DE (1) | DE3572807D1 (de) |
| DK (1) | DK53285A (de) |
| ES (1) | ES540172A0 (de) |
| FI (1) | FI850449L (de) |
| GR (1) | GR850309B (de) |
| IE (1) | IE850286L (de) |
| NO (1) | NO850444L (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3680184D1 (de) * | 1985-08-10 | 1991-08-14 | Beecham Group Plc | Verfahren zur herstellung von arylpiperidincarbinol. |
| IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
| GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
| GB9700690D0 (en) | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
| HUP0003958A3 (en) | 1997-05-29 | 2001-06-28 | Smithkline Beecham Plc | Process for preparation of 4-aryl-piperidines and intermediates |
| SI0994872T1 (de) * | 1997-06-10 | 2001-08-31 | Synthon Bv | |
| AU2002301956B2 (en) * | 1997-06-10 | 2006-02-09 | Synthon B.V. | 4-phenylpiperidine compounds |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9914583D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel process |
| CZ20023694A3 (cs) | 2000-05-12 | 2003-05-14 | Synthon B. V. | Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů |
| WO2002006275A1 (en) * | 2000-07-17 | 2002-01-24 | Smithkline Beecham P.L.C. | Novel processes for the preparation of 4-phenylpiperidine derivatives |
| WO2002028834A1 (en) * | 2000-10-06 | 2002-04-11 | Smithkline Beecham P.L.C. | Process for the preparation of aryl-piperidine carbinols and intermediates thereof |
| US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
| NL1017421C2 (nl) * | 2001-02-21 | 2002-01-15 | Synthon Bv | Werkwijze voor het vervaardigen van paroxetine. |
| US6930186B2 (en) | 2001-06-13 | 2005-08-16 | Teva Pharmacetical Industries Ltd. | Process for the preparation of paroxetine substantially free of alkoxy impurities |
| US20070142389A1 (en) * | 2005-12-20 | 2007-06-21 | Pfizer Inc. | Piperidine derivatives |
| JP5647519B2 (ja) | 2007-09-13 | 2014-12-24 | コンサート ファーマシューティカルズ インコーポレイテッド | 重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
-
1984
- 1984-02-07 US US06/577,844 patent/US4585777A/en not_active Expired - Lifetime
-
1985
- 1985-01-07 CA CA000471622A patent/CA1246082A/en not_active Expired
- 1985-02-04 FI FI850449A patent/FI850449L/fi not_active Application Discontinuation
- 1985-02-04 GR GR850309A patent/GR850309B/el unknown
- 1985-02-06 IE IE850286A patent/IE850286L/xx unknown
- 1985-02-06 NO NO850444A patent/NO850444L/no unknown
- 1985-02-06 AT AT85300793T patent/ATE46146T1/de not_active IP Right Cessation
- 1985-02-06 ES ES540172A patent/ES540172A0/es active Granted
- 1985-02-06 DE DE8585300793T patent/DE3572807D1/de not_active Expired
- 1985-02-06 JP JP60020218A patent/JPS60181071A/ja active Granted
- 1985-02-06 DK DK53285A patent/DK53285A/da not_active Application Discontinuation
- 1985-02-06 EP EP85300793A patent/EP0152273B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0152273A2 (de) | 1985-08-21 |
| EP0152273A3 (en) | 1986-12-30 |
| US4585777A (en) | 1986-04-29 |
| JPS60181071A (ja) | 1985-09-14 |
| FI850449L (fi) | 1985-08-08 |
| CA1246082A (en) | 1988-12-06 |
| ATE46146T1 (de) | 1989-09-15 |
| JPS6135176B2 (de) | 1986-08-12 |
| EP0152273B1 (de) | 1989-09-06 |
| IE850286L (en) | 1985-08-07 |
| ES8601131A1 (es) | 1985-11-16 |
| NO850444L (no) | 1985-08-08 |
| GR850309B (de) | 1985-06-05 |
| ES540172A0 (es) | 1985-11-16 |
| DE3572807D1 (en) | 1989-10-12 |
| FI850449A0 (fi) | 1985-02-04 |
| DK53285D0 (da) | 1985-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK53285A (da) | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme | |
| SE8602723D0 (sv) | Thiazoles, their production and pharmaceutical compositions containing them | |
| FI88037B (fi) | Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat | |
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| NO174239C (no) | Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat | |
| FI870219A (fi) | Hypoglykemiska tiazolidindioner. | |
| NO871408D0 (no) | Forbedringer ved farmasoeytiske akseptable salter. | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| DK0726899T3 (da) | Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler | |
| NO883229L (no) | Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater. | |
| NO862861D0 (no) | Fremgangsmaate for fremstilling av distamycinderivater. | |
| DK0506778T3 (da) | Substituerede 4-phenyl-4-piperidincarboxamider med både lokal anæstetisk og analgetisk virkning samt fremgangsmåder til deres fremstilling | |
| DK219685D0 (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler | |
| DK23289D0 (da) | Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse | |
| NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
| NO853782L (no) | Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater. | |
| DK412985D0 (da) | Prolinforbindelse og farmaceutisk praeparat indeholdende forbindelsen | |
| IL87561A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| DK313587D0 (da) | Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse | |
| DK89289D0 (da) | Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister | |
| DE3751597D1 (de) | Verwendung von 15-Deoxyspergualin als Arzneimittel. | |
| NO865004D0 (no) | Nye 16,17-acetalsubstituerte pregnan-21-oinsyre-derivater og fremgangsmaate for deres fremstilling. | |
| ES2016376B3 (es) | Acido n,n-bis-(4-fluorofenil) carbamoilacetohidroxamico y composicion farmaceutica que lo contiene. | |
| SE8500822D0 (sv) | Diazepinoindoles, their production and pharmaceutical compositions containing them | |
| KR880701228A (ko) | 2- 메틸-1,4- 디히드로피리딘, 그의 제조방법 및 이 화합물을 함유하는 제약 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |